Free tool
FAERS Monitor: Aricept
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020690 or its brand name (Aricept, Donepezil Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
19,997
Serious
14,679
73% of reports
Hospitalization
8,061
Death reported
3,033
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fall1,630
- confusional state1,125
- dizziness1,008
- death967
- nausea958
- diarrhoea943
- fatigue934
- asthenia847
- drug ineffective804
- hallucination779
- somnolence761
- vomiting697
- dementia623
- pneumonia623
- urinary tract infection613
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,108 |
| 2005 | 793 |
| 2006 | 806 |
| 2007 | 578 |
| 2008 | 692 |
| 2009 | 710 |
| 2010 | 948 |
| 2011 | 952 |
| 2012 | 956 |
| 2013 | 748 |
| 2014 | 853 |
| 2015 | 1,211 |
| 2016 | 1,076 |
| 2017 | 1,098 |
| 2018 | 920 |
| 2019 | 816 |
| 2020 | 706 |
| 2021 | 661 |
| 2022 | 888 |
| 2023 | 864 |
| 2024 | 916 |
| 2025 | 957 |
| 2026 | 739 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,162 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dementiaSignal | 623 | 24.0 | 22.2 | 13,395 |
| hallucinationSignal | 779 | 11.0 | 10.2 | 7,005 |
| confusional stateSignal | 1,125 | 7.4 | 7.0 | 6,189 |
| fallSignal | 1,630 | 5.2 | 4.9 | 5,542 |
| somnolenceSignal | 761 | 4.0 | 3.7 | 1,710 |
| urinary tract infectionSignal | 613 | 3.8 | 3.5 | 1,262 |
| astheniaSignal | 847 | 2.4 | 2.2 | 682 |
| dizzinessSignal | 1,008 | 2.1 | 2.0 | 615 |
| pneumoniaSignal | 623 | 2.0 | 1.9 | 327 |
| vomiting | 697 | 1.6 | 1.5 | 143 |
| diarrhoea | 943 | 1.5 | 1.4 | 182 |
| nausea | 958 | 1.3 | 1.2 | 58 |
| fatigue | 934 | 1.3 | 1.2 | 52 |
| death | 967 | 1.2 | 1.1 | 28 |
| drug ineffective | 804 | 0.6 | 0.6 | 171 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.